Compare
February 22, 2025 2025-02-22 23:41Compare
| Revolax SUB-Q with Lidocaine remove | Toxsta 100U remove | Etrebelle 200mg/vial remove | Elravie Ultra Volume-L remove | Dermalax Plus remove | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Name | Revolax SUB-Q with Lidocaine remove | Toxsta 100U remove | Etrebelle 200mg/vial remove | Elravie Ultra Volume-L remove | Dermalax Plus remove | ||||||||||
| Image |  |  |  |  |  | ||||||||||
| SKU | FM-02-51269 | FM-13-17854 | FM-02-83632 | FM-02-15519 | FM-02-33588 | ||||||||||
| Rating | |||||||||||||||
| Price | $37.00 | $67.00 | $154.00 | $43.00 | $38.00 | ||||||||||
| Stock | 1000 in stock | 1000 in stock | 1000 in stock | 1000 in stock | 1000 in stock | ||||||||||
| Availability | 1000 in stock | 1000 in stock | 1000 in stock | 1000 in stock | 1000 in stock | ||||||||||
| Add to cart | |||||||||||||||
| Description | |||||||||||||||
| Content | Revolax SUB-Q with Lidocaine has the thickest properties within the product line. With its advanced ability to mold, maintain structure and longevity, it is recommend for treatment of deep sized to extremely severe wrinkles including nasolabials and face (cheek, chin, or nose) contours. Revolax™ SUB-Q with Lidocaine is a biodegradable, non animal based, crosslinked dermal filler for subcutaneous implantation..
| Toxsta is the original strain from European National Institute and is a high-purity product with low immunogenicity risk that comlies with CGMP standards (FDA,EMA) for safe and fast skin and wrinkle improvement. Purpose of product usage: The product is used for wrinkle improvement on face and body. Packaging 1 vial/1box Expiry period 36 months | Main ingredients
Benefits of PLA microparticle
1 box – 1 vial, 200mg Injection needle: 21G-23G cannula. | Purpose of Elravie Premier Ultra Volume-L:
| Scope of Dermalax Plus:
The aesthetic effect lasts from 6 to 12 months. Product composition: HA 20 mg/ml, Lidocaine 0.3% Dermalax Plus 1 syringe ? 1.1 ml per pack Needle size: 30G Manufacturer: Hugel Pharma Co., Ltd., South Korea | ||||||||||
| Weight | N/A | N/A | N/A | N/A | N/A | ||||||||||
| Dimensions | N/A | N/A | N/A | N/A | N/A | ||||||||||
| Additional information |
|
|
|
|
|
